Ypsomed Holding AG

SWX:YPSN Stock Report

Market Cap: CHF 4.5b

Ypsomed Holding Valuation

Is YPSN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of YPSN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: YPSN (CHF326.5) is trading below our estimate of fair value (CHF517.83)

Significantly Below Fair Value: YPSN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for YPSN?

Key metric: As YPSN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for YPSN. This is calculated by dividing YPSN's market cap by their current earnings.
What is YPSN's PE Ratio?
PE Ratio59.9x
EarningsCHF 74.39m
Market CapCHF 4.46b

Price to Earnings Ratio vs Peers

How does YPSN's PE Ratio compare to its peers?

The above table shows the PE ratio for YPSN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average30.4x
ALC Alcon
36.3x9.9%CHF 37.6b
VBSN IVF Hartmann Holding
20.3xn/aCHF 357.2m
CLTN COLTENE Holding
24.4x22.3%CHF 301.2m
MOVE Medacta Group
40.5x21.1%CHF 2.1b
YPSN Ypsomed Holding
59.9x41.1%CHF 4.5b

Price-To-Earnings vs Peers: YPSN is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the peer average (30.4x).

Price to Earnings Ratio vs Industry

How does YPSN's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
YPSN 59.9xIndustry Avg. 29.6xNo. of Companies9PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: YPSN is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the European Medical Equipment industry average (29.6x).

Price to Earnings Ratio vs Fair Ratio

What is YPSN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

YPSN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio59.9x
Fair PE Ratio55.4x

Price-To-Earnings vs Fair Ratio: YPSN is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the estimated Fair Price-To-Earnings Ratio (55.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst YPSN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 326.50
CHF 426.00
+30.5%
15.4%CHF 495.00CHF 303.00n/a5
Dec ’25CHF 358.00
CHF 426.00
+19.0%
15.4%CHF 495.00CHF 303.00n/a5
Nov ’25CHF 387.50
CHF 426.20
+10.0%
13.0%CHF 495.00CHF 326.00n/a5
Oct ’25CHF 413.50
CHF 426.20
+3.1%
13.0%CHF 495.00CHF 326.00n/a5
Sep ’25CHF 415.00
CHF 426.20
+2.7%
13.0%CHF 495.00CHF 326.00n/a5
Aug ’25CHF 403.50
CHF 378.00
-6.3%
13.8%CHF 430.00CHF 326.00n/a2
Jul ’25CHF 408.00
CHF 378.00
-7.4%
13.8%CHF 430.00CHF 326.00n/a2
Jun ’25CHF 382.00
CHF 362.00
-5.2%
13.3%CHF 430.00CHF 326.00n/a3
May ’25CHF 329.00
CHF 351.33
+6.8%
9.8%CHF 400.00CHF 324.00n/a3
Nov ’24CHF 250.50
CHF 320.00
+27.7%
3.1%CHF 330.00CHF 310.00CHF 387.502
Oct ’24CHF 269.50
CHF 315.00
+16.9%
4.8%CHF 330.00CHF 300.00CHF 413.502
Sep ’24CHF 250.00
CHF 288.33
+15.3%
4.6%CHF 300.00CHF 270.00CHF 415.003
Aug ’24CHF 256.00
CHF 288.33
+12.6%
4.6%CHF 300.00CHF 270.00CHF 403.503
Jul ’24CHF 270.00
CHF 288.33
+6.8%
4.6%CHF 300.00CHF 270.00CHF 408.003
Jun ’24CHF 248.50
CHF 276.67
+11.3%
6.1%CHF 300.00CHF 260.00CHF 382.003
May ’24CHF 207.50
CHF 226.67
+9.2%
6.8%CHF 240.00CHF 205.00CHF 329.003
Apr ’24CHF 192.40
CHF 223.33
+16.1%
5.9%CHF 235.00CHF 205.00CHF 360.503
Mar ’24CHF 184.00
CHF 223.33
+21.4%
5.9%CHF 235.00CHF 205.00CHF 365.003
Feb ’24CHF 186.00
CHF 223.33
+20.1%
5.9%CHF 235.00CHF 205.00CHF 306.003
Jan ’24CHF 168.80
CHF 200.00
+18.5%
13.4%CHF 230.00CHF 165.00CHF 303.003
Dec ’23CHF 202.00
CHF 206.67
+2.3%
14.3%CHF 230.00CHF 165.00CHF 304.003

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 03:37
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ypsomed Holding AG is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carla BänzigerBank Vontobel AG
Gaurav JainBarclays
Curtis MoilesBNP Paribas Exane